Document Detail


Yttrium-90 Radioembolization is a Safe and Effective Treatment for Unresectable Hepatocellular Carcinoma: A Single Centre Experience of 45 Consecutive Patients.
MedLine Citation:
PMID:  25091398     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
INTRODUCTION: There is controversy regarding the role of yttrium-90 (90Y) radioembolization in the management of advanced, unresectable hepatocellular carcinoma (HCC).
METHODS: Forty-five consecutive patients underwent resin-based 90Y radioembolization for unresectable, HCC between 2006 and 2013 in Sydney, Australia. All patients were followed up with imaging studies at regular intervals until death. Radiologic response was evaluated with the Response Criteria in Solid Tumors (RECIST) criteria. Clinical toxicities were prospectively recorded. Survival was calculated by the Kaplan-Meier method and potential prognostic variables were identified on univariate and multivariate analysis.
RESULTS: Follow-up in the complete cohort was 7.8 (range, 0.1-41.8) months. The median survival after 90Y radioembolization was 27.7 months with a 36-month survival of 26%. By RECIST criteria of the 40 patients followed-up beyond 2 months, a complete response (CR) to treatment was observed in 1 patients (3%), partial response (PR) in 18(45%), stable disease (SD) in 11(22%) and progressive disease (PD) in 10(25%). On multivariate analysis only radiological response to treatment was independently associated with improved survival: CR/PR to treatment vs. SD vs. PD; p<0.001. Thirteen patients (29%) developed clinical toxicity after treatment; all complications were minor (grade I/II) and resolved without active intervention.
CONCLUSION: Radioembolization with 90Y is a safe and effective treatment for unresectable HCC.
Authors:
Akshat Saxena; Baerbel Meteling; Jada Kapoor; Sanjeev Golani; Mark Danta; David L Morris; Lourens Bester
Related Documents :
24503028 - Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retros...
23463098 - Efficacy and toxicity of trastuzumab and paclitaxel plus capecitabine in the first-line...
6456058 - Chemotherapy of pancreatic carcinoma.
23713048 - Histopathologic changes following neoadjuvant chemotherapy in locally advanced breast c...
20674068 - Palliative thoracic radiotherapy in non-small cell lung cancer. an analysis of 1250 pat...
2547888 - Adenoid cystic carcinoma of the salivary glands: clinicopathological survey of 51 patie...
Publication Detail:
Type:  REVIEW     Date:  2014-8-1
Journal Detail:
Title:  International journal of surgery (London, England)     Volume:  -     ISSN:  1743-9159     ISO Abbreviation:  Int J Surg     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101228232     Medline TA:  Int J Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014. Published by Elsevier Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Strategies for the Prevention of Oesophageal Adenocarcinoma.
Next Document:  Paravertebral Block for Video-Assisted Thoracoscopic Surgery: Analgesic Effectiveness and Role in Fa...